Big Pharma's $4.1B buying spree signals specialty shift
Supply Chain Pulse — 2026-05-11
Angelini Pharma's $4.1 billion acquisition of Catalyst Pharmaceuticals—expected to close Q3 2026—headlines a consolidation wave that's reshaping specialty drug access and pricing. MSD's completion of its Terns acquisition this week adds to the M&A momentum, while California hospitals are fighting back against Elevance's new out-of-network penalties that could cut payments by 10%. The pattern is clear: payers are tightening controls while drugmakers are doubling down on high-value therapeutics—leaving supply chain teams to navigate an increasingly concentrated landscape.
Quick Hits
- MSD completes Terns acquisition to expand chronic myeloid leukemia pipeline (Pharmaceutical Business Review)
- Major insurers flag AI risks, tariffs, and reputational damage in proxy statements (Modern Healthcare)
- Blue Shield of California's $500M PBM experiment shows mixed early results (Modern Healthcare)
- Advanced practice provider compensation varies widely by specialty, survey finds (Modern Healthcare)
Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1B
The Italian pharma giant's cash deal for the rare disease specialist is set to close in Q3 2026, bringing Catalyst's neuromuscular disorder treatments under European ownership. For supply chain teams, this means potential changes to distribution channels and inventory planning for specialized therapies that often require cold chain management and limited-source procurement.
Source: Pharmaceutical Business Review
California hospitals sue Elevance over 10% out-of-network penalty
The insurer's new policy would slash hospital payments by up to 10% when they refer commercial patients to out-of-network physicians, prompting a legal challenge from California hospital systems. This could force hospitals to restructure referral patterns and reconsider which specialists they contract with—impacting everything from surgical implant procurement to post-acute care coordination.
CMS' $50B rural health fund attracts major contractors
The federal Rural Health Transformation Program is drawing interest from large companies, but rural clinics worry contractors will take substantial cuts before funds reach patients. Supply chain leaders in rural markets should monitor which vendors win these contracts, as they'll likely influence technology adoption, group purchasing arrangements, and service delivery models across underserved areas.
Advanced practice provider pay structures evolving beyond salary
Employers are expanding compensation packages for PAs and nurse practitioners with new incentives as demand surges, according to Modern Healthcare's inaugural survey. For supply chain teams, this staffing shift means recalibrating procurement for different practice patterns—APPs often use different equipment preferences and may require additional training resources for complex medical devices.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe